TOMZ Achieves $500K Contract with Global Biopharmaceutical Leader

AI Summary

In the 2025 earnings call for TOMI Environmental Solutions (TOMZ), CEO Halden Shane reported significant milestones, including a $500,000 contract with a global biopharmaceutical leader for integration of their SteraMist Integration System in sterile manufacturing. By the end of 2025, TOMZ had secured four operational SIS installations. The company also made strides in the life sciences sector, winning a contract with NASA Johnson Space Center for biosecurity and expanding customer relationships in the eye health sector. These developments indicate growth potential and position TOMZ to capitalize on future revenue opportunities in 2026.